News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
COLA MICHAEL F
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/16/2023 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $56.1, valued at
$561k
|
|
| 05/30/2023 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 9,000 shares
@ $0
Granted 15,000 options to buy
@ $11.72, valued at
$175.8k
|
|
| 06/17/2022 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 9,947 options to buy
@ $31.36, valued at
$311.9k
|
|
| 05/27/2022 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 15,000 options to buy
@ $7.4, valued at
$111k
|
|
| 02/18/2022 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Bought 9,798 shares
@ $19, valued at
$186.2k
|
|
| 10/04/2021 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Avalo Therapeutics, Inc.|
Txns:
| Granted 78,116 options to buy
@ $2.25, valued at
$175.8k
|
|
| 07/02/2021 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 51,740 options to buy
@ $3.39, valued at
$175.4k
|
|
| 06/11/2021 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $76.09, valued at
$760.9k
|
|
| 05/24/2021 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 12,500 options to buy
@ $35.49, valued at
$443.6k
|
|
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2021 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 850,000 options to buy
@ $3.32, valued at
$2.8M
|
|
| 01/06/2021 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 64,798 options to buy
@ $2.64, valued at
$171.1k
|
|
| 10/02/2020 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 76,674 options to buy
@ $2.24, valued at
$171.7k
|
|
| 07/06/2020 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 64,683 options to buy
@ $2.56, valued at
$165.6k
|
|
| 06/22/2020 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 84,322 options to buy
@ $2.51, valued at
$211.6k
|
|
| 06/11/2020 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Bought 100,000 shares
@ $2.5, valued at
$250k
|
|
| 06/11/2020 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Aevi Genomic Medicine, LLC|
Txns:
| Bought 100,000 shares
@ $2.5, valued at
$250k
|
|
| 06/11/2020 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $36.47, valued at
$364.7k
|
|
| 05/22/2020 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Phathom Pharmaceuticals, Inc.|
Txns:
| Granted 10,000 options
@ $36.85, valued at
$368.5k
|
|
| 02/05/2020 |
4
| COLA MICHAEL F (CEO) has filed a Form 4 on Cerecor Inc.|
Txns:
| Granted 75,746 shares
@ $0
Granted 1,200,000 options to buy
@ $3.98, valued at
$4.8M
|
|
| 02/05/2020 |
3
| COLA MICHAEL F (CEO) has filed a Form 3 on Cerecor Inc. |
| 02/05/2020 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Disposed/sold 2,267,859 shares
@ $0
Disposed/sold 17,327 options to buy
@ $6.45, valued at
$111.8k
Disposed/sold 292,087 options to buy
@ $7.01, valued at
$2M
Disposed/sold 250,000 options to buy
@ $4.83, valued at
$1.2M
Disposed/sold 250,000 options to buy
@ $4.91, valued at
$1.2M
Disposed/sold 450,000 options to buy
@ $1.51, valued at
$679.5k
Disposed/sold 661,000 options to buy
@ $1.55, valued at
$1M
Disposed/sold 50,000 options to buy
@ $1.32, valued at
$66k
Disposed/sold 1,500,000 options to buy
@ $4.22, valued at
$6.3M
Disposed/sold 21,181 warrants
@ $2.84, valued at
$60.2k
|
|
| 12/09/2019 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Bought 2,049,376 shares
@ $0.134, valued at
$274.6k
|
|
| 10/24/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/17/2019 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $15.04, valued at
$150.4k
|
|
| 06/06/2019 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $177.41, valued at
$1.8M
|
|
| 06/18/2018 |
4
| COLA MICHAEL F (President and CEO) has filed a Form 4 on Aevi Genomic Medicine, Inc.|
Txns:
| Granted 661,000 options to buy
@ $1.55, valued at
$1M
|
|
| 06/15/2018 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Vanda Pharmaceuticals Inc.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $18.3, valued at
$183k
|
|
| 06/08/2018 |
4
| COLA MICHAEL F (Director) has filed a Form 4 on Sage Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $154.06, valued at
$1.5M
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2018 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 10/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|
|